当前位置：首页 > 文献互助 > 互助详情

期刊论文Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY复制

用户EO9nReo4Hj6s 34分钟前 6 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-15 17:23:10 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.jtho.2026.103577复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086426000304复制

其他信息:

出版社: Elsevier BV
作者: Pawan Kumar Singh

上一篇：Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial

下一篇：Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial

互助时间线

2026-09-08 17:24:35 [完结求助]

楼主确认了用户xcVfW0u4mDFJ应助的文件是正确的, 求助状态变成已完结

2026-09-08 17:23:10 [上传文件]

用户xcVfW0u4mDFJ上传了文件(pdf 220.84 KB), 求助状态变成待确认

2026-09-08 17:20:36 [发起求助]

最新发布的求助

Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial 16分钟前

Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY 34分钟前

Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial 49分钟前

https://doi.org/10.1063/1.3499306 1小时前

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial 1小时前

On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial 1小时前

Redox‐Neutral Vicinal Dialkylation of Aryl Boronic Esters via the Palladium/Norbornene Cooperative Catalysis 1小时前

CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer 1小时前

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial 1小时前

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study 1小时前

New and Practical Synthesis of N-(Pyrimidin-5-ylmethyl)pyridin-2-amine, the Key Intermediate to Triflumezopyrim 1小时前

6PPD-Q: A comprehensive critical review on environmental occurrence, toxicological mechanisms, risk assessment, and mitigating strategies 1小时前